Sally Bourliakas 💙
@SallyBourliakas
Followers
2K
Following
101K
Statuses
134K
Covid is Airborne wear FFP2/3 masks! Air filtration needed in schools & workplaces now! I’ve had long covid for 4+years. Mum, scientist, Sci-Fi reader ☮️ 🐈 🪄
Bicester England
Joined August 2012
LEARNING TO LIVE WITH COVID Isn’t an acceptable level of death/long covid that the GOV can sell the public. It’s: Clean air in schools & workplaces By Gov funded air filtration & ventilation (FFP2/3 masking indoors till then) Fully funded SSP Treatment & cures for #LongCovid
9
27
56
RT @polybioRF: 16/ “We know what long COVID clinical trials to run – and we have a plan to do it,” says Peluso. “Now we need everyone on bo…
0
5
0
RT @polybioRF: 15/ “Advancing such tests represents a major opportunity for the #biotech sector,” says report first author Amy Proal PhD, w…
0
3
0
RT @polybioRF: 14/ The report also highlights the urgent need to develop validated #biomarkers capable of detecting persistent virus in acc…
0
3
0
RT @polybioRF: 13/ “We believe that combining therapies targeting both the virus and the immune system may be the best way forward, especia…
0
5
0
RT @polybioRF: 12/ “Our approach recognizes the importance of a multifactorial strategy,” says report senior author Michael Peluso MD, an i…
0
4
0
RT @polybioRF: 13/ Combination Trials: Combining therapeutics – such as antivirals together with mAbs or immune system therapies – may be n…
0
4
0
RT @polybioRF: 12/ Viral RNA Targeting: Novel approaches such as CRISPR-based treatments could potentially deactivate persistent viral RNA,…
0
4
0
RT @polybioRF: 11/ Immunotherapies: Restoring effective immune function with therapies like cytokine treatments or immune modulators could…
0
5
0
RT @polybioRF: 10/ Antivirals: Short-term #antiviral trials for long COVID have shown mixed results, but longer treatment durations – simil…
0
6
0
RT @polybioRF: 9/ Monoclonal Antibodies (mAbs): mAbs could neutralize the virus or boost the #immune system’s ability to eliminate infected…
0
5
0
RT @polybioRF: 8/ Drawing on what scientists have learned from other viral infections such as #HIV, hepatitis C, and #cancer clinical trial…
0
5
0
RT @polybioRF: 7/ “I have been sick for four years and I know the science is there,” says long COVID patient Jon Douglas. “This report conf…
0
4
0
RT @polybioRF: 6/ The report, authored by 36 experts from 20 leading institutions worldwide, details key considerations for trial design, d…
0
5
0
RT @polybioRF: 5/ A new Viewpoint published in Lancet Infectious Diseases and supported by PolyBio Research Foundation provides a roadmap f…
0
6
0
RT @polybioRF: 4/ While early efforts are underway to treat these reservoirs, more well-designed clinical #trials are desperately needed to…
0
4
0
RT @polybioRF: 3/ Research increasingly links the condition and its symptoms to persistent SARS-CoV-2 #infection, with evidence showing tha…
0
7
0
RT @polybioRF: 2/ Long COVID, a debilitating condition following #SARS-CoV-2 infection, continues to disable tens of millions of people glo…
0
5
0